"10.1371_journal.pone.0014758","plos one","2011-03-11T00:00:00Z","Daniel A Kuppers; Harry C Hwang; Aimee L Jackson; Peter S Linsley; Bruce E Clurman; Matthew L Fero","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Rosetta Inpharmatics, Seattle, Washington, United States of America","Conceived and designed the experiments: PSL MLF. Performed the experiments: DAK MLF. Analyzed the data: DAK ALJ MLF. Contributed reagents/materials/analysis tools: HCH ALJ PSL BEC MLF. Wrote the paper: MLF.","Salary support in the form of research grants from the NIH and NCI was provided to M. Fero, H. Hwang, B. Clurman. Both Regulus Inc. and Rosetta Inpharmatics, Inc (a subsidiary of Merck Inc.) have approved or pending patents involving miRNA and microarray technology. The Fred Hutchinson Cancer Research Center holds patents on p27-deficient mouse models. All individuals received salary support from their host institutions. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","03","Daniel A Kuppers","DAK",6,TRUE,2,2,3,1,TRUE,TRUE,FALSE,0,NA,FALSE
